Longeveron Inc (LGVN)
1.72
-0.10
(-5.49%)
USD |
NASDAQ |
Apr 24, 16:00
1.90
+0.18
(+10.47%)
After-Hours: 06:57
Longeveron Profit Margin (Quarterly): -9.57K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -9.57K% |
| September 30, 2023 | -3.40K% |
| June 30, 2023 | -2.60K% |
| March 31, 2023 | -1.67K% |
| December 31, 2022 | -3.68K% |
| September 30, 2022 | -1.98K% |
| June 30, 2022 | -1.21K% |
| March 31, 2022 | -948.6% |
| December 31, 2021 | -1.95K% |
| Date | Value |
|---|---|
| September 30, 2021 | -2.09K% |
| June 30, 2021 | -1.02K% |
| March 31, 2021 | -827.4% |
| December 31, 2020 | -114.9% |
| September 30, 2020 | -50.29% |
| June 30, 2020 | -138.8% |
| March 31, 2020 | -12.47% |
| December 31, 2019 | -67.34% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-9.57K%
Minimum
Dec 2023
-12.47%
Maximum
Mar 2020
-1.84K%
Average
-1.21K%
Median
Jun 2022
Profit Margin (Quarterly) Benchmarks
| Palatin Technologies Inc | -385.6% |
| BioSig Technologies Inc | -50.41K% |
| Adial Pharmaceuticals Inc | -- |
| Outset Medical Inc | -126.5% |
| MSP Recovery Inc | -3.22K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -174.2% |
| Return on Assets | -118.9% |
| Return on Invested Capital | -174.2% |
| Gross Profit Margin (Quarterly) | -3.17% |
| Operating Margin (Quarterly) | -8.63K% |
| Return on Net Operating Assets | -322.5% |